Exane Derivatives’s Yamana Gold, Inc. AUY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-35,657
Closed -$204K 975
2020
Q4
$204K Sell
35,657
-54,833
-61% -$308K 0.06% 307
2020
Q3
$514K Sell
90,490
-9,866
-10% -$59.1K 0.15% 127
2020
Q2
$548K Buy
100,356
+18,209
+22% +$87K 0.15% 121
2020
Q1
$226K Sell
82,147
-20,254
-20% -$76.4K 0.06% 183
2019
Q4
$391K Sell
102,401
-104,739
-51% -$368K 0.07% 196
2019
Q3
$659K Sell
207,140
-150,888
-42% -$481K 0.12% 137
2019
Q2
$902K Sell
358,028
-311,029
-46% -$684K 0.16% 109
2019
Q1
$1.75M Buy
669,057
+631,714
+1,692% +$1.64M 0.35% 78
2018
Q4
$88.1K Buy
+37,343
New +$87.1K 0.02% 327
2018
Q3
Sell
-170,674
Closed -$502K 731
2018
Q2
$502K Sell
170,674
-38,745
-19% -$113K 0.08% 182
2018
Q1
$564K Buy
209,419
+171,046
+446% +$528K 0.11% 157
2017
Q4
$119K Buy
38,373
+33,682
+718% +$89.9K 0.02% 276
2017
Q3
$12.4K Sell
4,691
-103,765
-96% -$276K ﹤0.01% 381
2017
Q2
$263K Sell
108,456
-190,542
-64% -$514K 0.06% 188
2017
Q1
$825K Buy
298,998
+180,012
+151% +$544K 0.19% 98
2016
Q4
$334K Buy
+118,986
New +$389K 0.07% 184

Other funds holding AUY

Exane Derivatives's AUY Position: Q1 2021 in Review

Exane Derivatives sold out of Yamana Gold, Inc. (AUY) in Q1 2021, closing a stake of 35,657 shares — an estimated $204K sold.

Exane Derivatives first reported a position in AUY in Q4 2016 and held it in 16 quarters. The position peaked at $1.75M in Q1 2019. 274 funds tracked by Wall St. Rank hold AUY as of Q1 2021.

  • Exane Derivatives reported no remaining Yamana Gold, Inc. position as of Q1 2021 after selling out during the quarter.
  • Exane Derivatives sold 35,657 Yamana Gold, Inc. shares in Q1 2021, an estimated $204K.
  • Exane Derivatives first reported a position in Yamana Gold, Inc. in Q4 2016 and held it in 16 quarters.
  • Exane Derivatives's Yamana Gold, Inc. position peaked at $1.75M in Q1 2019.
  • 274 funds tracked by Wall St. Rank held Yamana Gold, Inc. as of Q1 2021.

Based on Exane Derivatives's 13F filing for Q1 2021, filed 30 Apr 2021.